Piramal Imaging SA

Type: Company
Name: Piramal Imaging SA
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

WVU Healthcare performs first US commercial Neuraceq scan

Neuraceq is a radiopharmaceutical from Piramal Imaging for Beta-Amyloid Plaque ImagingWVU Healthcare in West Virginia, is the first centre in the US to perform commercial scans using Neuraceq. It became available for commercial use in August, marking ... [Published Express Healthcare Management - Sep 11 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 1 reports

Top 13 most powerful businesswomen in India

A look at what the 13 women in Business Today 's elite Most Powerful Women in Indian Business list have been up to recently -Kiran Mazumdar-ShawCMD, Biocon LtdIn January, her company's partnership with Mylan helped launch a biosimilar and a targeted therapy ... [Published Business Today India - Aug 14 2014]
First reported Aug 13 2014 - Updated Aug 14 2014 - 3 reports

First U.S. commercial Neuraceq scan for beta-amyloid plaque imaging

Piramal Imaging (Berlin) reported that WVU Healthcare (Morgantown, West Virginia) is the first U.S. center to perform commercial scans using the company's Neuraceq, which just became available for commercial use on Aug. 1.Neuraceq, which received marketing ... [Published Medical Device Daily - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Piramal Imaging announce WVU Healthcare in West Virginia

First US Commercial Neuraceq Scan for Beta-Amyloid Plaque Imaging Performed at WVU Healthcare. Piramal Imaging announced that WVU Healthcare in West Virginia, is the first center in the United States to perform commercial scans using Neuraceq. Neuraceq ... [Published India Infoline - Aug 12 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

Research on Piramal Imaging's Neuraceq(TM) (Florbetaben F18 Injection) Takes Center Stage at SNMMI

BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Jun 10, 2014) - Piramal Imaging today released details from research presented at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), currently underway ... [Published Marketwire - Breaking News Releases - Jun 10 2014]
First reported Jun 06 2014 - Updated Jun 06 2014 - 1 reports

Piramal Imaging Research Key Topic at Society of Nuclear Medicine and Molecular Imaging Annual Meeting

BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Jun 6, 2014) - Piramal Imaging today announced that 12 presentations at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), being held June 7 - 11 at the ... [Published Marketwire - Breaking News Releases - Jun 06 2014]
First reported May 12 2014 - Updated May 13 2014 - 1 reports

AC Immune and Piramal Imaging Announce Out-Licensing Agreement for the Development of Tau Protein Diagnostics in Alzheimer's Disease

LAUSANNE, SWITZERLAND and BERLIN, GERMANY and BOSTON, MA--(Marketwired - May 12, 2014) - ... [Published Marketwire - Breaking News Releases - May 12 2014]
First reported Apr 30 2014 - Updated May 01 2014 - 1 reports

Neuraceq(TM) (Florbetaben F18 Injection) Data: an Emerging Science Topic at the American Academy of Neurology Annual Meeting in Philadelphia

BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Apr 30, 2014) - Piramal Imaging today announced that data from its beta-amyloid PET tracer NeuraceqT clinical trial will be featured as part of Emerging Science sessions at the 66th American ... [Published Marketwire - Breaking News Releases - Apr 30 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

NEURACEQ (Florbetaben F 18) Injection, Solution [Piramal Imaging, SA]

Entities: Piramal Imaging SA
First reported Mar 20 2014 - Updated Mar 20 2014 - 1 reports

FDA Approves Piramal Imaging's Neuraceq™ (florbetaben F18 injection) for PET Imaging of Beta-Amyloid Neuritic Plaques in the Brain

BERLIN and BOSTON, March 20, 2014 /PRNewswire/ -- Piramal Imaging today announced that the U.S. Food and Drug Administration (FDA) has approved Neuraceq™. This approval comes only four weeks after receiving marketing authorization for Neuraceq™ from ... [Published PR Newswire: Policy & Public Interest - Mar 20 2014]

Quotes

Under her leadership, the company reported a net profit of ` "544 crore in FY14, up 12 per cent from the previous year. She is also among the highest paid women heads of a company with a compensation of `7.16 crore during FY14."
...to beta-amyloid imaging with florbetaben without enrolling in a research trial," said Gary Marano, medical director of nuclear medicine and PET/CT. "For us as clinicians, it's a new diagnostic option to offer patients and referring physicians in cases of cognitive decline and concerns for Alzheimer's disease."
...opinion, recommending the granting of a marketing authorisation for the medicinal product Neuraceq with the following therapeutic indication. "This medicinal product is for diagnostic use only. Neuraceq is a radiopharmaceutical indicated for Positron Emission Tomography (PET) imaging of ß-amyloid neuritic plaque density in the brains of adult patients with cognitive impairment who are being evaluated for Alzheimer's disease (AD) and other causes of cognitive impairment. Neuraceq should be used in conjunction with a clinical evaluation."

More Content

All (15) | News (9) | Reports (0) | Blogs (6) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
WVU Healthcare performs first US commercial Neu... [Published Express Healthcare Management - Sep 11 2014]
Piramal marks Neuraceq 1st commercial U.S. use [Published Aunt Minnie - Aug 21 2014]
Top 13 most powerful businesswomen in India [Published Business Today India - Aug 14 2014]
First U.S. commercial Neuraceq scan for beta-am... [Published Medical Device Daily - Aug 14 2014]
WVU Healthcare performs first US commercial Neu... [Published MedicalPhysicsWeb - Aug 13 2014]
First commercial use of Neuraceq beta-amyloid PET [Published MolecularImaging.net - Aug 13 2014]
Piramal Imaging announce WVU Healthcare in West... [Published India Infoline - Aug 12 2014]
Research on Piramal Imaging's Neuraceq(TM) (Flo... [Published Marketwire - Breaking News Releases - Jun 10 2014]
Piramal Imaging Research Key Topic at Society o... [Published Marketwire - Breaking News Releases - Jun 06 2014]
AC Immune and Piramal Imaging Announce Out-Lice... [Published Marketwire - Breaking News Releases - May 12 2014]
Neuraceq(TM) (Florbetaben F18 Injection) Data: ... [Published Marketwire - Breaking News Releases - Apr 30 2014]
NEURACEQ (Florbetaben F 18) Injection, Solution... [Published DailyMed Drug Label Updates for the last seven ... - Apr 02 2014]
FDA Approves Piramal Imaging's Neuraceq™ (florb... [Published PR Newswire: Policy & Public Interest - Mar 20 2014]
CHMP adopts positive opinion for Neuraceq [Published Pharmaceutical Business Review - Dec 24 2013]
CHMP recommends Piramal Imagingâs NeuraCeq for ... [Published PharmaBiz - Dec 20 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research on Piramal Imaging's Neuraceq(TM) (Flo... [Published Marketwire - Breaking News Releases - Jun 10 2014]
BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Jun 10, 2014) - Piramal Imaging today released details from research presented at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), currently underway ...
Piramal Imaging Research Key Topic at Society o... [Published Marketwire - Breaking News Releases - Jun 06 2014]
BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Jun 6, 2014) - Piramal Imaging today announced that 12 presentations at the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), being held June 7 - 11 at the ...
AC Immune and Piramal Imaging Announce Out-Lice... [Published Marketwire - Breaking News Releases - May 12 2014]
LAUSANNE, SWITZERLAND and BERLIN, GERMANY and BOSTON, MA--(Marketwired - May 12, 2014) - ...
Neuraceq(TM) (Florbetaben F18 Injection) Data: ... [Published Marketwire - Breaking News Releases - Apr 30 2014]
BERLIN, GERMANY and BOSTON, MA and MUMBAI, INDIA--(Marketwired - Apr 30, 2014) - Piramal Imaging today announced that data from its beta-amyloid PET tracer NeuraceqT clinical trial will be featured as part of Emerging Science sessions at the 66th American ...
NEURACEQ (Florbetaben F 18) Injection, Solution... [Published DailyMed Drug Label Updates for the last seven ... - Apr 02 2014]
Updated Date: Apr 2, 2014 EST ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.